Health Discoveries in Bone Cancer
-
Drug gains FDA priority review to treat metastatic bone cancer
August 4, 2010
The drug denosumab, recently approved for treating postmenopausal osteoporosis, has been granted priority review by the U.S. Food and Drug Administration (FDA) for patients who develop metastatic bone cancer.
More...